CBD and other hemp cannabinoids reduce inflammation through multiple pathways: CB2 receptor activation (anti-inflammatory immune modulation), TRPV1 receptor modulation (pain and inflammation signaling), and indirect effects on prostaglandin synthesis. A 2015 review in Bioorganic & Medicinal Chemistry found CBD inhibited inflammatory markers including TNF-α, IL-1β, and IL-6 in preclinical models. Beta-caryophyllene, a terpene found in hemp, binds CB2 receptors directly and showed anti-inflammatory effects in a 2014 study in European Journal of Pharmacology. The clinical evidence is more limited than preclinical data — the best-established human use is CBD's FDA-approved application in Epidiolex (for seizures), though the anti-inflammatory properties underlying it are relevant to broader inflammatory conditions. Hemp isn't a replacement for medical anti-inflammatory treatment, but it has a real pharmacological basis for the reported benefits.

Which cannabinoid is most anti-inflammatory?

CBD has the most clinical research on anti-inflammatory applications. CBG (cannabigerol) is increasingly studied for inflammatory bowel conditions — a 2013 study in Biochemical Pharmacology found CBG reduced inflammation in a model of murine colitis. CBN has shown anti-inflammatory activity in preclinical studies. For topical inflammation (joint pain, muscle soreness), full spectrum hemp extracts applied topically are popular and have local CB receptor access without systemic absorption. For systemic inflammation, oral full spectrum CBD at 25–75mg/day is the most commonly used approach.

Is hemp better for inflammation than NSAIDs?

Not as a replacement, but potentially as a complement. NSAIDs (ibuprofen, naproxen) have well-established COX-1/COX-2 inhibition efficacy for acute inflammation and are more acutely potent than hemp cannabinoids at standard doses. Hemp's advantage is a side effect profile that doesn't include the gastrointestinal risk of NSAIDs or the cardiovascular risk of high-dose NSAIDs with long-term use. Many users combine low-dose NSAIDs with hemp products for inflammation management, allowing lower NSAID doses while maintaining overall effect.

What hemp products are best for inflammation?

Full spectrum CBD oil (orally, 25–75mg/day) addresses systemic inflammation. Topical CBD/hemp extract salves and balms target local joint or muscle inflammation without systemic absorption. THCA (raw, unheated) has anti-inflammatory properties distinct from THC — THCA doesn't bind CB1 receptors but may have anti-inflammatory activity through separate pathways. Find full spectrum hemp and THCA products at Elevated Haze.